Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04084548 · ClinicalTrials.gov registry record · Phase 3

Perioperative Lidocaine and Ketamine in Abdominal Surgery

A Phase 3 study of Postoperative Pain, sponsored by The Cleveland Clinic.

Active
Registry status
Phase 3
Development phase
420
Enrollment target
1
Study location

NCT04084548 is a Phase 3 study of Postoperative Pain that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 420 participants, above the 225-participant average among 63 other Postoperative Pain trials with a reported enrollment target (87% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04084548, a Phase 3 study of Postoperative Pain, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
420 participants
Enrollment target
1
Study location

Study Summary

The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Ketamine
  • DRUG Lidocaine
  • DRUG Lidocaine and ketamine

Study Locations (1)

Florida

  • Cleveland Clinic Florida - Weston

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2019-10-15
Est. Completion 2025-12
Phase Phase 3

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04084548

The ClinicalTrials.gov registry entry for NCT04084548 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 225-participant average among 63 other Postoperative Pain trials with a reported enrollment target (87% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT04084548 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04084548 about?

NCT04084548 is a clinical study titled "Perioperative Lidocaine and Ketamine in Abdominal Surgery". The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.

What is the current status of trial NCT04084548?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 420 participants. The study started on 2019-10-15. Estimated completion is 2025-12.

What conditions does trial NCT04084548 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT04084548?

The interventions under investigation include: Placebo (DRUG), Ketamine (DRUG), Lidocaine (DRUG), Lidocaine and ketamine (DRUG).

Who is sponsoring clinical trial NCT04084548?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04084548 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.